Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P

Cancer Letters

Volumn 129, Issue 1, 1998, Pages 69-76

  Chuman, Yutaka ^a   Chen, Zhe Sheng ^a   Seto, Kiyotomo ^b   Sumizawa, Tomoyuki ^a   Furukawa, Tatsuhiko ^a   Tani, Ayako ^a   Haraguchi, Misako ^a   Niwa, Kiyoshi ^a   Yamada, Kazutaka ^a   Aikou, Takashi ^a   Akiyama, Shin ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

BSO; MDR; MRP; P gp; PAK 104P

Indexed keywords

5 (4,6 DIMETHYL 1,3,2 DIOXAPHOSPHORINAN 2 YL) 2,6 DIMETHYL 4 (3 NITROPHENYL) 3 PYRIDINECARBOXYLIC ACID 2 (4 BENZHYDRYL 1 PIPERAZINYL)ETHYL ESTER P OXIDE; ADENOSINE TRIPHOSPHATE; BUTHIONINE SULFOXIMINE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; PYRIDINE DERIVATIVE; TRITIUM; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CELL STRAIN KB; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOASSAY;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BUTHIONINE SULFOXIMINE; CYCLIC P-OXIDES; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENZYME INHIBITORS; GLUTAMATE-CYSTEINE LIGASE; HUMANS; NICOTINIC ACIDS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VINCRISTINE;

TRITIUM;

EID: 0032479566     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00083-4     Document Type: Article

References (34)

1. Akiyama S., Fojo A., Hanover J.A., Pastan I., Gottesman M.M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat. Cell Mol. Genet. 11:1985;117.
2. Barrand M.A., Heppell-Parton A.C., Wright K.A., Rabbitts P.H., Twentyman P.R. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J. Natl. Cancer Inst. 86:1994;110-117.
3. Bradley G., Juranka P.F., Ling V. Mechanism of multidrug resistance. Biochim. Biophys. Acta. 948:1988;87-128.
4. Chuman Y., Sumizawa T., Takebayashi Y., Niwa K., Yamada K., Haraguchi M., Furukawa T., Akiyama S., Aikou T. Expression of the multidrug resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int. J. Cancer. 66:1996;274-279.
5. Cole S.P.C., Bhardwa J.G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
6. Cornwell M.M., Horio M., Gottesman M.M., Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. USA. 85:1988;3580-3584.
7. Deffie A.M., Batra J.K., Goldenberg G.J. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and resistant P388 leukemia cell lines. Cancer Res. 49:1989;58-62.
8. Dejong S., Zijlstra J.G., Devries E.G.E., Mulder N.H. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 50:1990;304-309.
9. Fojo A.T., Akiyama S., Gottesman M.M., Pastan I. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res. 45:1985;3002-3007.
10. 4) receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208:1995;345-352.
11. Giaccone G., Gazdar A.F., Beck H., Zunino F., Capranico G. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res. 52:1992;1666-1674.
12. Hyafil F., Vergely C., Vingnaud P.D., Perret T.G. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53:1993;4595-4602.
13. Ishikawa T., Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. J. Biol. Chem. 268:1993;20116-20125.
14. 2+-dependent cardiac transport system for glutathione S-conjugates. J. Biol. Chem. 264:1989;17343-17348.
15. Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:1994;4833-4836.
16. Kartner N., Evernden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature. 316:1985;820-823.
17. Krishnamachary N., Center M.S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:1993;3658-3661.
18. Kubo H., Sumizawa T., Koga K., Nishiyama K., Takebayashi Y., Chuman Y., Furukawa T., Akiyama S., Ohi Y. Expression of the multidrug resistance-associated protein (MRP) gene in urotherial carcinomas. Int. J. Cancer. 69:1996;488-494.
19. 4 and structurally related conjugates. J. Biol. Chem. 269:1994;27807-27810.
20. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport is a plasma membrane drug-efflux pump. J. Biol. Chem. 271:1996;9675-9682.
21. Loe D.W., Deeley R.G., Cole S.P.C. Biology of the multidrug resistance protein, MRP. Eur. J. Cancer. 32A:1996;945-957.
22. Muller M., Meijer C., Zaman G.J.R., Borst P., Scheper R.J., Mulder N.H., Devries E.G.E., Jansen P.L.M. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA. 91:1994;13033-13037.
23. Owen W.G., Alton M. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254:1979;7558-7560.
24. Paul S., Breuninger L.M., Tew K.D., Shen H., Kruh G.D. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. Proc. Natl. Acad. Sci. USA. 93:1996;6929-6934.
25. Per S.R., Mattern M.R., Mirabelli C.K., Drake F.H., Johnson R.K., Crooke S.T. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function. Mol. Pharmacol. 32:1987;17-25.
26. Scheper R.J., Broxterman H.J., Scheffer G.L., Kaaijk P., Dalton W.S., van Heijningen T.H., van Kalken C.K., Slovak M.L., de Vries E.G.E., van der Valk P., Meijer C.J.L.M., Pinedo H.M. Overexpression of a Mr 100000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53:1993;1475-1479.
27. Shen D.-w., Cardarelli C., Hwang J., Cornwell M., Richert N., Ishii I., Pastan I., Gottesman M.M. Multiple drug-resistance to colchicine, adriamycin or vinblastine show changes in expression of specific protein. J. Biol. Chem. 261:1986;7762-7770.
28. Shudo N., Mizoguchi T., Kiyosue T., Arita M., Yoshimura A., Seto K., Sakoda R., Akiyama S. Two pyridine analogs with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Cancer Res. 50:1990;3055-3061.
29. Slapak C.A., Mizunuma N., Kufe D.W. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood. 84:1994;3113-3121.
30. Sumizawa T., Chuman Y., Sakamoto H., Iemura K., Almquist K.C., Deeley R.G., Cole S.P.C., Akiyama S. Non-P-glycoprotein-mediated multidrug resistant human KB cells selected in medium containing adriamycin, cepharanthine and mezerein. Somat. Cell Mol. Genet. 20:1994;423-435.
31. Sumizawa T., Chen Z.-s., Chuman Y., Seto K., Furukawa T., Haraguchi M., Tani A., Shudo N., Akiyama S. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. Mol. Pharmacol. 51:1997;399-405.
32. Twentyman P.R., Reeve J.G., Koch G., Wright K.A. Chemosensitization by verapamil and cyclosporin-A in mouse tumor cells expressing different levels of P-glycoprotein and CP22 (SORCIN). Br. J. Cancer. 62:1990;89-95.
33. Yusa K., Tsuruo T. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 49:1989;5002-5006.
34. Zaman G.J.R., Lankelma J., Tellingen O., Beijnen J., Dekker H., Paulusma C., Oude Elferink R.P.J., Baas F., Borst P. Role of glutathione in the export of compounds from cells by the multidrug-resistance associated protein. Proc. Natl. Acad. Sci. USA. 92:1995;7690.